Does BELIMUMAB Cause Myelosuppression? 6 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Myelosuppression have been filed in association with BELIMUMAB (BENLYSTA). This represents 0.0% of all adverse event reports for BELIMUMAB.
6
Reports of Myelosuppression with BELIMUMAB
0.0%
of all BELIMUMAB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Myelosuppression From BELIMUMAB?
Of the 6 reports, 4 (66.7%) required hospitalization.
Is Myelosuppression Listed in the Official Label?
Yes, Myelosuppression is listed as a known adverse reaction in the official FDA drug label for BELIMUMAB.
What Other Side Effects Does BELIMUMAB Cause?
Product dose omission issue (4,671)
Systemic lupus erythematosus (3,388)
Fatigue (1,650)
Drug ineffective (1,570)
Pain (1,510)
Wrong technique in device usage process (1,347)
Injection site pain (1,279)
Malaise (1,257)
Headache (1,207)
Arthralgia (1,114)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which BELIMUMAB Alternatives Have Lower Myelosuppression Risk?
BELIMUMAB vs BELINOSTAT
BELIMUMAB vs BELUMOSUDIL
BELIMUMAB vs BELVIQ
BELIMUMAB vs BELZUTIFAN
BELIMUMAB vs BEMPEDOIC ACID